Alpine Global Management, LLC Ocugen, Inc. Transaction History

Alpine Global Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.18 - $1.98 $285,926 - $479,775	242,311 New	242,311 $375,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.1 $18,287 - $32,395	10,450 New	10,450 $19,000
Q2 2022 Aug 15, 2022	SELL	$1.83 - $3.45 $14,601 - $27,527	-7,979 Reduced 43.3%	10,450 $24,000
Q1 2022 May 13, 2022	SELL	$2.34 - $4.72 $2,847 - $5,744	-1,217 Reduced 6.19%	18,429 $61,000
Q4 2021 Feb 14, 2022	BUY	$4.38 - $15.67 $86,049 - $307,852	19,646 New	19,646 $89,000
Q1 2021 May 13, 2021	SELL	$1.66 - $15.81 $492,198 - $4.69 Million	-296,505 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$0.28 - $2.6 $83,021 - $770,913	296,505 New	296,505 $543,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $167M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.